Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.


Science 27 September 1985:
Vol. 229. no. 4720, pp. 1358 - 1365
DOI: 10.1126/science.2994218

Articles

Science, Vol 229, Issue 4720, 1358-1365
Copyright © 1985 by American Association for the Advancement of Science


articles

Three-dimensional structure of poliovirus at 2.9 A resolution

JM Hogle, M Chow, and DJ Filman

The three-dimensional structure of poliovirus has been determined at 2.9 A resolution by x-ray crystallographic methods. Each of the three major capsid proteins (VP1, VP2, and VP3) contains a "core" consisting of an eight-stranded antiparallel beta barrel with two flanking helices. The arrangement of beta strands and helices is structurally similar and topologically identical to the folding pattern of the capsid proteins of several icosahedral plant viruses. In each of the major capsid proteins, the "connecting loops" and NH2- and COOH-terminal extensions are structurally dissimilar. The packing of the subunit "cores" to form the virion shell is reminiscent of the packing in the T = 3 plant viruses, but is significantly different in detail. Differences in the orientations of the subunits cause dissimilar contacts at protein-protein interfaces, and are also responsible for two major surface features of the poliovirion: prominent peaks at the fivefold and threefold axes of the particle. The positions and interactions of the NH2- and COOH-terminal strands of the capsid proteins have important implications for virion assembly. Several of the "connecting loops" and COOH-terminal strands form prominent radial projections which are the antigenic sites of the virion.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Foot-and-Mouth Disease Virus Assembly: Processing of Recombinant Capsid Precursor by Exogenous Protease Induces Self-Assembly of Pentamers In Vitro in a Myristoylation-Dependent Manner.
S. Goodwin, T. J. Tuthill, A. Arias, R. A. Killington, and D. J. Rowlands (2009)
J. Virol. 83, 11275-11282
   Abstract »    Full Text »    PDF »
Biological and immunological characteristics of hepatitis E virus-like particles based on the crystal structure.
T. Yamashita, Y. Mori, N. Miyazaki, R. H. Cheng, M. Yoshimura, H. Unno, R. Shima, K. Moriishi, T. Tsukihara, T. C. Li, et al. (2009)
PNAS 106, 12986-12991
   Abstract »    Full Text »    PDF »
Comparison of poliovirus recombinants: accumulation of point mutations provides further advantages.
C. Savolainen-Kopra, E. Samoilovich, H. Kahelin, A.-K. Hiekka, T. Hovi, and M. Roivainen (2009)
J. Gen. Virol. 90, 1859-1868
   Abstract »    Full Text »    PDF »
Antibodies to the Buried N Terminus of Rhinovirus VP4 Exhibit Cross-Serotypic Neutralization.
U. Katpally, T.-M. Fu, D. C. Freed, D. R. Casimiro, and T. J. Smith (2009)
J. Virol. 83, 7040-7048
   Abstract »    Full Text »    PDF »
Environmental Poliovirus Surveillance during Oral Poliovirus Vaccine and Inactivated Poliovirus Vaccine Use in Cordoba Province, Argentina.
J. E. Mueller, M. Bessaud, Q. S. Huang, L. C. Martinez, P. A. Barril, V. Morel, J. Balanant, J. Bocacao, J. Hewitt, B. D. Gessner, et al. (2009)
Appl. Envir. Microbiol. 75, 1395-1401
   Abstract »    Full Text »    PDF »
Crystal structure of CD155 and electron microscopic studies of its complexes with polioviruses.
P. Zhang, S. Mueller, M. C. Morais, C. M. Bator, V. D. Bowman, S. Hafenstein, E. Wimmer, and M. G. Rossmann (2008)
PNAS 105, 18284-18289
   Abstract »    Full Text »    PDF »
Changes in Population Dynamics during Long-Term Evolution of Sabin Type 1 Poliovirus in an Immunodeficient Patient.
J. K. Odoom, Z. Yunus, G. Dunn, P. D. Minor, and J. Martin (2008)
J. Virol. 82, 9179-9190
   Abstract »    Full Text »    PDF »
Characterization of the New World Monkey Homologues of Human Poliovirus Receptor CD155.
S. Khan, X. Peng, J. Yin, P. Zhang, and E. Wimmer (2008)
J. Virol. 82, 7167-7179
   Abstract »    Full Text »    PDF »
The molecular basis of mouse adaptation by human enterovirus 71.
B. H. Chua, P. Phuektes, S. A. Sanders, P. K. Nicholls, and P. C. McMinn (2008)
J. Gen. Virol. 89, 1622-1632
   Abstract »    Full Text »    PDF »
Calibration of Multiple Poliovirus Molecular Clocks Covering an Extended Evolutionary Range.
J. Jorba, R. Campagnoli, L. De, and O. Kew (2008)
J. Virol. 82, 4429-4440
   Abstract »    Full Text »    PDF »
Chemical mimicry of viral capsid self-assembly.
A. J. Olson, Y. H. E. Hu, and E. Keinan (2007)
PNAS 104, 20731-20736
   Abstract »    Full Text »    PDF »
Pocket Factors Are Unlikely To Play a Major Role in the Life Cycle of Human Rhinovirus.
U. Katpally and T. J. Smith (2007)
J. Virol. 81, 6307-6315
   Abstract »    Full Text »    PDF »
Inactivation of Poliovirus 1 and F-Specific RNA Phages and Degradation of Their Genomes by UV Irradiation at 254 Nanometers.
J. Simonet and C. Gantzer (2006)
Appl. Envir. Microbiol. 72, 7671-7677
   Abstract »    Full Text »    PDF »
An aged host promotes the evolution of avirulent coxsackievirus into a virulent strain.
R. T. Gay, S. Belisle, M. A. Beck, and S. N. Meydani (2006)
PNAS 103, 13825-13830
   Abstract »    Full Text »    PDF »
Structural and Functional Insights into the Interaction of Echoviruses and Decay-accelerating Factor.
D. M. Pettigrew, D. T. Williams, D. Kerrigan, D. J. Evans, S. M. Lea, and D. Bhella (2006)
J. Biol. Chem. 281, 5169-5177
   Abstract »    Full Text »    PDF »
Characterization of Early Steps in the Poliovirus Infection Process: Receptor-Decorated Liposomes Induce Conversion of the Virus to Membrane-Anchored Entry-Intermediate Particles.
T. J. Tuthill, D. Bubeck, D. J. Rowlands, and J. M. Hogle (2006)
J. Virol. 80, 172-180
   Abstract »    Full Text »    PDF »
Alignment of capsid protein VP1 sequences of all human rhinovirus prototype strains: conserved motifs and functional domains.
P. Laine, S. Blomqvist, C. Savolainen, K. Andries, and T. Hovi (2006)
J. Gen. Virol. 87, 129-138
   Abstract »    Full Text »    PDF »
Susceptibility of coxsackievirus B3 laboratory strains and clinical isolates to the capsid function inhibitor pleconaril: antiviral studies with virus chimeras demonstrate the crucial role of amino acid 1092 in treatment.
M. Schmidtke, E. Hammerschmidt, S. Schuler, R. Zell, E. Birch-Hirschfeld, V. A. Makarov, O. B. Riabova, and P. Wutzler (2005)
J. Antimicrob. Chemother. 56, 648-656
   Abstract »    Full Text »    PDF »
The Structure of the Poliovirus 135S Cell Entry Intermediate at 10-Angstrom Resolution Reveals the Location of an Externalized Polypeptide That Binds to Membranes.
D. Bubeck, D. J. Filman, N. Cheng, A. C. Steven, J. M. Hogle, and D. M. Belnap (2005)
J. Virol. 79, 7745-7755
   Abstract »    Full Text »    PDF »
Interaction of tSNARE Syntaxin 18 with the Papillomavirus Minor Capsid Protein Mediates Infection.
I. Bossis, R. B. S. Roden, R. Gambhira, R. Yang, M. Tagaya, P. M. Howley, and P. I. Meneses (2005)
J. Virol. 79, 6723-6731
   Abstract »    Full Text »    PDF »
Temperature-sensitive mutants of enterovirus 71 show attenuation in cynomolgus monkeys.
M. Arita, H. Shimizu, N. Nagata, Y. Ami, Y. Suzaki, T. Sata, T. Iwasaki, and T. Miyamura (2005)
J. Gen. Virol. 86, 1391-1401
   Abstract »    Full Text »    PDF »
Novel [(biphenyloxy)propyl]isoxazole derivatives for inhibition of human rhinovirus 2 and coxsackievirus B3 replication.
V. A. Makarov, O. B. Riabova, V. G. Granik, P. Wutzler, and M. Schmidtke (2005)
J. Antimicrob. Chemother. 55, 483-488
   Abstract »    Full Text »    PDF »
Long-Term Excretion of Vaccine-Derived Poliovirus by a Healthy Child.
J. Martin, K. Odoom, G. Tuite, G. Dunn, N. Hopewell, G. Cooper, C. Fitzharris, K. Butler, W. W. Hall, and P. D. Minor (2004)
J. Virol. 78, 13839-13847
   Abstract »    Full Text »    PDF »
Mutation in Enterovirus 71 Capsid Protein VP1 Confers Resistance to the Inhibitory Effects of Pyridyl Imidazolidinone.
S.-R. Shih, M.-C. Tsai, S.-N. Tseng, K.-F. Won, K.-S. Shia, W.-T. Li, J.-H. Chern, G.-W. Chen, C.-C. Lee, Y.-C. Lee, et al. (2004)
Antimicrob. Agents Chemother. 48, 3523-3529
   Abstract »    Full Text »    PDF »
Putative Autocleavage of Outer Capsid Protein {micro}1, Allowing Release of Myristoylated Peptide {micro}1N during Particle Uncoating, Is Critical for Cell Entry by Reovirus.
A. L. Odegard, K. Chandran, X. Zhang, J. S. L. Parker, T. S. Baker, and M. L. Nibert (2004)
J. Virol. 78, 8732-8745
   Abstract »    Full Text »    PDF »
Mechanism of Action at the Molecular Level of the Antiviral Drug 3(2H)-Isoflavene against Type 2 Poliovirus.
A. L. Salvati, A. De Dominicis, S. Tait, A. Canitano, A. Lahm, and L. Fiore (2004)
Antimicrob. Agents Chemother. 48, 2233-2243
   Abstract »    Full Text »    PDF »
Virus-Binding Proteins Recovered from Bacterial Culture Derived from Activated Sludge by Affinity Chromatography Assay Using a Viral Capsid Peptide.
D. Sano, T. Matsuo, and T. Omura (2004)
Appl. Envir. Microbiol. 70, 3434-3442
   Abstract »    Full Text »    PDF »
Foot-and-Mouth Disease.
M. J. Grubman and B. Baxt (2004)
Clin. Microbiol. Rev. 17, 465-493
   Abstract »    Full Text »    PDF »
VP1 Sequencing of All Human Rhinovirus Serotypes: Insights into Genus Phylogeny and Susceptibility to Antiviral Capsid-Binding Compounds.
R. M. Ledford, N. R. Patel, T. M. Demenczuk, A. Watanyar, T. Herbertz, M. S. Collett, and D. C. Pevear (2004)
J. Virol. 78, 3663-3674
   Abstract »    Full Text »    PDF »
Virucidal Efficacy of Glutaraldehyde against Enteroviruses Is Related to the Location of Lysine Residues in Exposed Structures of the VP1 Capsid Protein.
M. Chambon, C. Archimbaud, J.-L. Bailly, J.-M. Gourgand, F. Charbonne, and H. Peigue-Lafeuille (2004)
Appl. Envir. Microbiol. 70, 1717-1722
   Abstract »    Full Text »    PDF »
The Structure of Echovirus Type 12 Bound to a Two-domain Fragment of Its Cellular Attachment Protein Decay-accelerating Factor (CD 55).
D. Bhella, I. G. Goodfellow, P. Roversi, D. Pettigrew, Y. Chaudhry, D. J. Evans, and S. M. Lea (2004)
J. Biol. Chem. 279, 8325-8332
   Abstract »    Full Text »    PDF »
Evolution of wild-type 1 poliovirus in two healthy siblings excreting the virus over a period of 6 months.
T. Hovi, N. Lindholm, C. Savolainen, M. Stenvik, and C. Burns (2004)
J. Gen. Virol. 85, 369-377
   Abstract »    Full Text »    PDF »
Genetic variability of hepatitis A virus.
M. Costa-Mattioli, A. D. Napoli, V. Ferre, S. Billaudel, R. Perez-Bercoff, and J. Cristina (2003)
J. Gen. Virol. 84, 3191-3201
   Abstract »    Full Text »    PDF »
Complete Genomic Sequencing Shows that Polioviruses and Members of Human Enterovirus Species C Are Closely Related in the Noncapsid Coding Region.
B. Brown, M. S. Oberste, K. Maher, and M. A. Pallansch (2003)
J. Virol. 77, 8973-8984
   Abstract »    Full Text »    PDF »
Genome Delivery and Ion Channel Properties Are Altered in VP4 Mutants of Poliovirus.
P. Danthi, M. Tosteson, Q.-h. Li, and M. Chow (2003)
J. Virol. 77, 5266-5274
   Abstract »    Full Text »    PDF »
Crystal Structure of Swine Vesicular Disease Virus and Implications for Host Adaptation.
E. E. Fry, N. J. Knowles, J. W. I. Newman, G. Wilsden, Z. Rao, A. M. Q. King, and D. I. Stuart (2003)
J. Virol. 77, 5475-5486
   Abstract »    Full Text »    PDF »
Complexes of Poliovirus Serotypes with Their Common Cellular Receptor, CD155.
Y. He, S. Mueller, P. R. Chipman, C. M. Bator, X. Peng, V. D. Bowman, S. Mukhopadhyay, E. Wimmer, R. J. Kuhn, and M. G. Rossmann (2003)
J. Virol. 77, 4827-4835
   Abstract »    Full Text »    PDF »
Galactose is needed only for expression of co-receptors used by Theiler's murine encephalomyelitis virus as the virus does not directly bind galactose or use the UDP-galactose transporter as a receptor.
H. V. Reddi, P. Kallio, and H. L. Lipton (2003)
J. Gen. Virol. 84, 845-849
   Abstract »    Full Text »    PDF »
Amino Acid Substitutions in VP2 Residues Contacting Sialic Acid in Low-Neurovirulence BeAn Virus Dramatically Reduce Viral Binding and Spread of Infection.
A. S. M. Kumar, P. Kallio, M. Luo, and H. L. Lipton (2003)
J. Virol. 77, 2709-2716
   Abstract »    Full Text »    PDF »
Genome Variability and Capsid Structural Constraints of Hepatitis A Virus.
G. Sanchez, A. Bosch, and R. M. Pinto (2003)
J. Virol. 77, 452-459
   Abstract »    Full Text »    PDF »
Molecular Evolution of Hepatitis A Virus: a New Classification Based on the Complete VP1 Protein.
M. Costa-Mattioli, J. Cristina, H. Romero, R. Perez-Bercof, D. Casane, R. Colina, L. Garcia, I. Vega, G. Glikman, V. Romanowsky, et al. (2002)
J. Virol. 76, 9516-9525
   Abstract »    Full Text »    PDF »
Chemical Synthesis of Poliovirus cDNA: Generation of Infectious Virus in the Absence of Natural Template.
J. Cello, A. V. Paul, and E. Wimmer (2002)
Science 297, 1016-1018
   Abstract »    Full Text »    PDF »
Analysis of Deletion Mutants Indicates that the 2A Polypeptide of Hepatitis A Virus Participates in Virion Morphogenesis.
L. Cohen, D. Benichou, and A. Martin (2002)
J. Virol. 76, 7495-7505
   Abstract »    Full Text »    PDF »
Picornavirus uncoating.
M S Smyth and J H Martin (2002)
Mol. Pathol. 55, 214-219
   Abstract »    Full Text »    PDF »
Long-Term Circulation of Vaccine-Derived Poliovirus That Causes Paralytic Disease.
E. A. Cherkasova, E. A. Korotkova, M. L. Yakovenko, O. E. Ivanova, T. P. Eremeeva, K. M. Chumakov, and V. I. Agol (2002)
J. Virol. 76, 6791-6799
   Abstract »    Full Text »    PDF »
Characterization of CHAT and Cox Type 1 Live-Attenuated Poliovirus Vaccine Strains.
J. Martin and P. D. Minor (2002)
J. Virol. 76, 5339-5349
   Abstract »    Full Text »    PDF »
Supramolecular Chemistry And Self-assembly Special Feature: Organization of the interior of molecular capsules by hydrogen bonding.
J. L. Atwood, L. J. Barbour, and A. Jerga (2002)
PNAS 99, 4837-4841
   Abstract »    Full Text »    PDF »
Molecular Genetic Analysis of Revertants from a Poliovirus Mutant That Is Specifically Adapted to the Mouse Spinal Cord.
Q. Jia, J. M. Hogle, T. Hashikawa, and A. Nomoto (2001)
J. Virol. 75, 11766-11772
   Abstract »    Full Text »    PDF »
Sequence Conservation and Antigenic Variation of the Structural Proteins of Equine Rhinitis A Virus.
A. Varrasso, H. E. Drummer, J.-a. Huang, R. A. Stevenson, N. Ficorilli, M. J. Studdert, and C. A. Hartley (2001)
J. Virol. 75, 10550-10556
   Abstract »    Full Text »    PDF »
Foot-and-mouth disease virus can utilize the C-terminal extension of coxsackievirus A9 VP1 for cell infection.
M. Leippert and E. Pfaff (2001)
J. Gen. Virol. 82, 1703-1711
   Abstract »    Full Text »    PDF »
Type-Specific Detection of Echovirus 30 Isolates Using Degenerate Reverse Transcriptase PCR Primers.
D. R. Kilpatrick, J. Quay, M. A. Pallansch, and M. S. Oberste (2001)
J. Clin. Microbiol. 39, 1299-1302
   Abstract »    Full Text »    PDF »
Interaction of Coxsackievirus A21 with Its Cellular Receptor, ICAM-1.
C. Xiao, C. M. Bator, V. D. Bowman, E. Rieder, Y. He, B. Hebert, J. Bella, T. S. Baker, E. Wimmer, R. J. Kuhn, et al. (2001)
J. Virol. 75, 2444-2451
   Abstract »    Full Text »    PDF »
Coxsackievirus A9 VP1 Mutants with Enhanced or Hindered A Particle Formation and Decreased Infectivity.
A. Airaksinen, M. Roivainen, and T. Hovi (2001)
J. Virol. 75, 952-960
   Abstract »    Full Text »    PDF »
Interaction of Recombinant Norwalk Virus Particles with the 105-Kilodalton Cellular Binding Protein, a Candidate Receptor Molecule for Virus Attachment.
M. Tamura, K. Natori, M. Kobayashi, T. Miyamura, and N. Takeda (2000)
J. Virol. 74, 11589-11597
   Abstract »    Full Text »    PDF »
Combined Cell Culture Enzyme-Linked Immunosorbent Assay for Quantification of Poliovirus Neutralization- Relevant Antibodies.
A. F. Wahby (2000)
Clin. Vaccine Immunol. 7, 915-919
   Abstract »    Full Text »    PDF »
Cell-free synthesis of poliovirus: 14S subunits are the key intermediates in the encapsidation of poliovirus RNA.
Y. Verlinden, A. Cuconati, E. Wimmer, and B. Rombaut (2000)
J. Gen. Virol. 81, 2751-2754
   Abstract »    Full Text »
Coxsackievirus Expression of the Murine Secretory Protein Interleukin-4 Induces Increased Synthesis of Immunoglobulin G1 in Mice.
N. M. Chapman, K.-S. Kim, S. Tracy, J. Jackson, K. Hofling, J. S. Leser, J. Malone, and P. Kolbeck (2000)
J. Virol. 74, 7952-7962
   Abstract »    Full Text »    PDF »
Antigenic properties of human parechovirus 1.
P. Joki-Korpela, M. Roivainen, H. Lankinen, T. Pöyry, and T. Hyypiä (2000)
J. Gen. Virol. 81, 1709-1718
   Abstract »    Full Text »
Genomic Determinants of Cardiovirulence in Coxsackievirus B3 Clinical Isolates: Localization to the 5' Nontranslated Region.
J. J. Dunn, N. M. Chapman, S. Tracy, and J. R. Romero (2000)
J. Virol. 74, 4787-4794
   Abstract »    Full Text »    PDF »
Mutation of Predicted Virion Pit Residues Alters Binding of Theiler's Murine Encephalomyelitis Virus to BHK-21 Cells.
S. Hertzler, M. Luo, and H. L. Lipton (2000)
J. Virol. 74, 1994-2004
   Abstract »    Full Text »    PDF »
Genomic Variations in Echovirus 30 Persistent Isolates Recovered from a Chronically Infected Immunodeficient Child and Comparison with the Reference Strain.
J.-L. Bailly, M. Chambon, C. Henquell, J. Icart, and H. Peigue-Lafeuille (2000)
J. Clin. Microbiol. 38, 552-557
   Abstract »    Full Text »    PDF »
Molecular Tectonic Model of Virus Structural Transitions: the Putative Cell Entry States of Poliovirus.
D. M. Belnap, D. J. Filman, B. L. Trus, N. Cheng, F. P. Booy, J. F. Conway, S. Curry, C. N. Hiremath, S. K. Tsang, A. C. Steven, et al. (2000)
J. Virol. 74, 1342-1354
   Abstract »    Full Text »    PDF »
From the Cover: Three-dimensional structure of poliovirus receptor bound to poliovirus.
D. M. Belnap, B. M. McDermott Jr., D. J. Filman, N. Cheng, B. L. Trus, H. J. Zuccola, V. R. Racaniello, J. M. Hogle, and A. C. Steven (2000)
PNAS 97, 73-78
   Abstract »    Full Text »    PDF »
From the Cover: Interaction of the poliovirus receptor with poliovirus.
Y. He, V. D. Bowman, S. Mueller, C. M. Bator, J. Bella, X. Peng, T. S. Baker, E. Wimmer, R. J. Kuhn, and M. G. Rossmann (2000)
PNAS 97, 79-84
   Abstract »    Full Text »    PDF »
Antibody Responses to Antigenic Sites 1 and 3 of Serotype 3 Poliovirus after Vaccination with Oral Live Attenuated or Inactivated Poliovirus Vaccine and after Natural Exposure.
T. Herremans, J. H. J. Reimerink, T. G. Kimman, H. G. A. M. van der Avoort, and M. P. G. Koopmans (2000)
Clin. Vaccine Immunol. 7, 40-44
   Abstract »    Full Text »    PDF »
Structural Fingerprinting: Subgrouping of Comoviruses by Structural Studies of Red Clover Mottle Virus to 2.4-A Resolution and Comparisons with Other Comoviruses.
T. Lin, A. J. Clark, Z. Chen, M. Shanks, J.-B. Dai, Y. Li, T. Schmidt, P. Oxelfelt, G. P. Lomonossoff, and J. E. Johnson (2000)
J. Virol. 74, 493-504
   Abstract »    Full Text »    PDF »
Poliovirus Mutants at Histidine 195 of VP2 Do Not Cleave VP0 into VP2 and VP4.
M. Hindiyeh, Q.-H. Li, R. Basavappa, J. M. Hogle, and M. Chow (1999)
J. Virol. 73, 9072-9079
   Abstract »    Full Text »    PDF »
Site-saturation mutagenesis of the PALTAVETG motif in coxsackievirus A9 capsid protein VP1 reveals evidence of conservation of a periodic hydrophobicity profile.
A. Airaksinen, M. Roivainen, G. Stanway, and T. Hovi (1999)
J. Gen. Virol. 80, 1919-1927
   Abstract »    Full Text »
Isolation and Molecular Characterization of a Poliovirus Type 1 Mutant That Replicates in the Spinal Cords of Mice.
Q. Jia, S. Ohka, K. Iwasaki, K. Tohyama, and A. Nomoto (1999)
J. Virol. 73, 6041-6047
   Abstract »    Full Text »    PDF »
Molecular Evolution of the Human Enteroviruses: Correlation of Serotype with VP1 Sequence and Application to Picornavirus Classification.
M. S. Oberste, K. Maher, D. R. Kilpatrick, and M. A. Pallansch (1999)
J. Virol. 73, 1941-1948
   Abstract »    Full Text »    PDF »
The Reovirus Mutant tsA279 L2 Gene Is Associated with Generation of a Spikeless Core Particle: Implications for Capsid Assembly.
P. R. Hazelton and K. M. Coombs (1999)
J. Virol. 73, 2298-2308
   Abstract »    Full Text »    PDF »
Interaction of Poliovirus with Its Receptor Affords a High Level of Infectivity to the Virion in Poliovirus Infections Mediated by the Fc Receptor.
M. Arita, H. Horie, M. Arita, and A. Nomoto (1999)
J. Virol. 73, 1066-1074
   Abstract »    Full Text »    PDF »
Prolonged Replication of a Type 1 Vaccine-Derived Poliovirus in an Immunodeficient Patient.
O. M. Kew, R. W. Sutter, B. K. Nottay, M. J. McDonough, D. R. Prevots, L. Quick, and M. A. Pallansch (1998)
J. Clin. Microbiol. 36, 2893-2899
   Abstract »    Full Text »    PDF »
The Poliovirus Empty Capsid Specifically Recognizes the Poliovirus Receptor and Undergoes Some, but Not All, of the Transitions Associated with Cell Entry.
R. Basavappa, A. Gomez-Yafal, and J. M. Hogle (1998)
J. Virol. 72, 7551-7556
   Abstract »    Full Text »    PDF »
Interaction of Poliovirus with Its Purified Receptor and Conformational Alteration in the Virion.
M. Arita, S. Koike, J. Aoki, H. Horie, and A. Nomoto (1998)
J. Virol. 72, 3578-3586
   Abstract »    Full Text »    PDF »
WIN 52035-Dependent Human Rhinovirus 16: Assembly Deficiency Caused by Mutations near the Canyon Surface.
W. Wang, W.-M. Lee, A. G. Mosser, and R. R. Rueckert (1998)
J. Virol. 72, 1210-1218
   Abstract »    Full Text »    PDF »
NMR Studies on the Flexibility of the Poliovirus C3 Linear Epitope Inserted into Different Sites of the Maltose-binding Protein.
A. Lecroisey, P. Martineau, M. Hofnung, and M. Delepierre (1997)
J. Biol. Chem. 272, 362-368
   Abstract »    Full Text »    PDF »
Identification of the integrin VLA-2 as a receptor for echovirus 1.
J. Bergelson, M. Shepley, B. Chan, M. Hemler, and R. Finberg (1992)
Science 255, 1718-1720
   Abstract »    PDF »
Cell-free, de novo synthesis of poliovirus.
A Molla, A. Paul, and E Wimmer (1991)
Science 254, 1647-1651
   Abstract »    PDF »
Poliovirus mutants resistant to neutralization with soluble cell receptors.
G Kaplan, D Peters, and V. Racaniello (1990)
Science 250, 1596-1599
   Abstract »    PDF »
Protein-RNA interactions in an icosahedral virus at 3.0 A resolution.
Z. Chen, C Stauffacher, Y Li, T Schmidt, W Bomu, G Kamer, M Shanks, G Lomonossoff, and J. Johnson (1989)
Science 245, 154-159
   Abstract »    PDF »
Poliovirus host range is determined by a short amino acid sequence in neutralization antigenic site I.
M. Murray, J Bradley, X. Yang, E Wimmer, E. Moss, and V. Racaniello (1988)
Science 241, 213-215
   Abstract »    PDF »
Location and chemical synthesis of a binding site for HIV-1 on the CD4 protein.
B. Jameson, P. Rao, L. Kong, B. Hahn, G. Shaw, L. Hood, and S. Kent (1988)
Science 240, 1335-1339
   Abstract »    PDF »
The atomic structure of Mengo virus at 3.0 A resolution.
M Luo, G Vriend, G Kamer, I Minor, E Arnold, M. Rossmann, U Boege, D. Scraba, G. Duke, and A. Palmenberg (1987)
Science 235, 182-191
   Abstract »    PDF »
A poliovirus neutralization epitope expressed on hybrid hepatitis B surface antigen particles.
F Delpeyroux, N Chenciner, A Lim, Y Malpiece, B Blondel, R Crainic, S van der Werf, and R. Streeck (1986)
Science 233, 472-475
   Abstract »    PDF »
Three-dimensional structure of the adenovirus major coat protein hexon.
M. Roberts, J. White, M. Grutter, and R. Burnett (1986)
Science 232, 1148-1151
   Abstract »    PDF »
Two Distinct Binding Affinities of Poliovirus for Its Cellular Receptor.
B. M. McDermott Jr., A. H. Rux, R. J. Eisenberg, G. H. Cohen, and V. R. Racaniello (2000)
J. Biol. Chem. 275, 23089-23096
   Abstract »    Full Text »    PDF »
Virus Maturation Targets the Protein Capsid to Concerted Disassembly and Unfolding.
A. C. Oliveira, A. M. O. Gomes, F. C. L. Almeida, R. Mohana-Borges, A. P. Valente, V. S. Reddy, J. E. Johnson, and J. L. Silva (2000)
J. Biol. Chem. 275, 16037-16043
   Abstract »    Full Text »    PDF »
Supramolecular Chemistry And Self-assembly Special Feature: Organization of the interior of molecular capsules by hydrogen bonding.
J. L. Atwood, L. J. Barbour, and A. Jerga (2002)
PNAS 99, 4837-4841
   Abstract »    Full Text »    PDF »



To Advertise     Find Products


Science. ISSN 0036-8075 (print), 1095-9203 (online)